Avenue therapeutics reports first quarter 2023 financial results and recent corporate highlights

Miami, may 12, 2023 (globe newswire) -- avenue therapeutics, inc. (nasdaq: atxi) (“avenue” or the “company”), a specialty pharmaceutical company focused on the development and commercialization of therapies for the treatment of neurologic diseases, today reported financial results and recent corporate highlights for the first quarter ended march 31, 2023.
ATXI Ratings Summary
ATXI Quant Ranking